BiedenkopfLab
banner
biedenkopflab.bsky.social
BiedenkopfLab
@biedenkopflab.bsky.social
Highly motivated, in mechanistic studies of viral replication of highly pathogenic viruses (Ebola virus, Marburg virus) interested group at the Institute of Virology, Philipps-Universität Marburg
Happy to participate again in the #NSV2025 meeting in Montpellier. Great science, great social events, great place to be :-)
June 24, 2025 at 9:07 AM
Had a wonderful time at the #GfV2025 annual virology meeting in Hamburg, starting already with our youngPI meeting at the BNI and a great social evening at the town hall :-)
Sunny spring in Hamburg :-)
March 7, 2025 at 1:29 PM
Reposted by BiedenkopfLab
We had a fantastic kick-off meeting at @helmholtzhzi.bsky.social Braunschweig the last two days. What a great consortium🤩. Thanks everyone for coming. I am looking forward to dive into #COMBINE-MARV
January 21, 2025 at 5:57 PM
Super exited to share that our EU funded project COMBINE has finally kicked off! Super proud to be part of this inspiring initiative with great scientists across Europe. Looking forward to 5 years research on Marburg virus :-)
🔗 www.combine-marv.eu
#EU #HaDEA
January 21, 2025 at 6:00 PM
Super proud and thankful to the
Von Behring Röntgen Foundation
for funding our research on Ebola virus NP post translational modifications ! 😀
www.br-stiftung.de/aktuelles/de...
January 16, 2025 at 5:56 PM
Please find here our newest research paper on Ebola virus Nucleoprotein phosphorylation, published as christmas present in Emerging Microbes and Infections :-) what a good start into 2025, happy new year!
www.tandfonline.com/doi/10.1080/...
To be or not to be phosphorylated: Understanding the role of Ebola virus nucleoprotein in the dynamic interplay with the transcriptional activator VP30 and the host phosphatase PP2A-B56
Ebola virus (EBOV) transcription is essentially regulated via dynamic dephosphorylation of its viral transcription activator VP30 by the host phosphatase PP2A. The nucleoprotein NP has emerged as a...
www.tandfonline.com
January 3, 2025 at 9:23 AM